Meredith Salisburyis an editorial director and a senior consultant for the life science communications firm Bioscribe.
Solving any disease is hard, but solving rare disease is a special kind of torture. Take everything that must be accomplished with any old disease—What causes it? Under what circumstances...
In the not-too-distant future, crime scene analysts will be gathering a lot more than human DNA in their quest for trace evidence. The microbiome, or the universe of bacteria and other mi...
By some estimates, as many as half a million people have had their genomes sequenced—through research projects, clinical programs, or consumer services. In the next few years, that number...
President Obama’s optimistic language about finally nearing a cure for cancer in last week’s State of the Union address comes at a time when creative approaches are showing more promise t...
